Introduction
============

The study of personality is key in the efforts to predict treatment adherence and health care behaviors, as well as to evaluate their influence on the management and clinical control of chronic disease (eg, diabetes, heart failure, cancer, and HIV/AIDS.).[@b1-prbm-11-459] Traditionally, the concept of personality has been defined as traits or stable predispositions, including dimensions such as conscientiousness, extraversion, introversion, submission, dominance, neuroticism, and psychoticism.[@b2-prbm-11-459]--[@b4-prbm-11-459] Based on these dimensions, different studies have been conducted in the last two decades in order to prove the relationship between personality and treatment-adherence behaviors, as well as the impact of personality on quality of life and the clinical progression of chronic diseases, such as HIV/AIDS.[@b5-prbm-11-459]--[@b7-prbm-11-459]

Nevertheless, the problem underlying in this definition is that persons are grouped into preestablished categories, considering them as equivalent members of the same class; furthermore, with such a classification, reactive forms of behavior (eg, physiological response patterns and socially valued behaviors) are analyzed as general behavioral predispositions, but not as modes of interaction between individuals and contextual situations.[@b8-prbm-11-459] Following Ribe's proposal of personality,[@b8-prbm-11-459],[@b9-prbm-11-459] and according to Ryle's analytic philosophy,[@b10-prbm-11-459] the terms coming from the ordinary language for describing psychological events can be grouped into different logical categories, known as dispositional categories; these have to do with sets or collections of past or present events, not with particular past or present events. In psychology, the terms of ordinary language are functionally related to, or are a consequence of, the capacities (what a person can competently do), propensities (why the person does certain things and in what social circumstances), and tendencies (how is it that the person behaves consistently over time and between different situations).

The concept of personality describes the particular modes of behavior (as interactive styles), as a tendency along the time and in situations that are not socially valued, that is, in situations in which the person is not expected to do something or behave in a certain way. Therefore, the concept of personality allows us to identify and predict how a person interacts consistently with other persons in different situations. The emphasis is on how each person behaves at the individual level, according to a unique functional profile.[@b8-prbm-11-459],[@b11-prbm-11-459] From this theoretical perspective, experimental research has included the study of interactive styles such as risk tendency,[@b12-prbm-11-459] persistence to achievement,[@b13-prbm-11-459] tolerance to frustration,[@b14-prbm-11-459] and tolerance to ambiguity.[@b15-prbm-11-459]

Based on this theoretical proposal, some years ago, Piña and Sánchez-Sosa[@b16-prbm-11-459] developed a psychological model for the research of treatment-adherence behaviors in persons living with chronic diseases, including the design and validation of two self-administered instruments. The first one is for measuring two psychological variables: motives and behavioral competencies related to the practice of treatment adherence and health care behaviors.[@b17-prbm-11-459] The second one is for measuring four interactive styles of personality related to stressful situations when receiving treatment for a chronic disease: 1) Decision Making (DM) is defined as a style of behavior with which a person faces one or more situations in which a response option is demanded and the person perceives it, or a response option is demanded and the person does not perceive it, or the person perceives a demand to response that does not exist; 2) Tolerance to Ambiguity (TA) is defined as a situation in which there is a demand to do something and the person behaves, but there is no relationship between the demand and the consequences that are obtained when behaving; 3) Tolerance to Frustration is defined as a situation in which a person behaves in a certain way and the consequence that is obtained is less than expected, is delayed, not delivered, or requires for a greater execution; and 4) Impulsivity is defined as a lack of correspondence between the stimuli and the reactions to them, in situations in which their relationships are not homogeneous.[@b9-prbm-11-459]

This proposal of four interactive styles of personality gave rise to 12-item Stress-Related Situations Scale (SRSS-12).[@b18-prbm-11-459] The validation study of the SRSS-12, performed among Mexican HIV-positive patients, showed a three-factor structure that explained 70.5% of the total variance: DM, TA, and TF/I.[@b19-prbm-11-459] Recently, the SRSS-12 was adapted and validated in women diagnosed with breast cancer in Peru. The exploratory factor analysis (EFA) yielded two factors that explained the 59.9% of total variance: Tolerance to Frustration/Ambiguity (TFA) (raw Cronbach's alpha =0.88) and DM (raw Cronbach's alpha =0.70).[@b20-prbm-11-459] The three-factor model was not tested using confirmatory factor analysis (CFA) in this last research. Because of these results, we consider that the process of adaptation and validation in other countries can contribute to clarifying the factor structure of the scale, verify its reliability, and deepen its application to predict the role of personality in treatment adherence and health care behaviors among people living with a chronic disease.

Thus, the objectives of this study were to test the expected model of three factors, prove the convergent and discriminate validity of these factors, verify the internal consistency of the scale and its factors, and describe the distributions of factor scores. In this study, we hypothesized that a three-factor structure, like that obtained in the original validation study in Mexico,[@b19-prbm-11-459] could be reproduced in Venezuela: TF/I (items 1, 2, 3, 4, 8, and 9); TA (items 5, 6, and 7); and DM (items 10, 11, and 12). Nevertheless, there may be a lack of discriminant validity between the TF/I and TA factors, which would bring them together as a single factor within a two-factor model as the model observed in Peru.[@b20-prbm-11-459] A high (raw Cronbach's alpha ≥0.80)[@b20-prbm-11-459] or a very high (raw Cronbach's alpha ≥0.90)[@b19-prbm-11-459] internal consistency was expected for the scale, as well as acceptable to high for the three factors (raw Cronbach's alpha ≥0.70).[@b20-prbm-11-459] Finally, the distributions of the factor scores could follow a normal distribution because these factors evaluate personality dimensions.[@b21-prbm-11-459]

Patients and methods
====================

Study setting and participants
------------------------------

This cross-sectional study was conducted between May and June 2016. The sampling was nonprobabilistic. The intentional sample composed of 194 out of 400 HIV-positive patients receiving attention in a health care center of the National Program for the Control of AIDS (PRONASIDA, by its Spanish acronym), located in the city of Barquisimeto (Lara, Venezuela). The participation percentage was 90.6% (194 out of 214 persons who were invited). Eight out of 194 cases were dropped due to missing data. Therefore, the analyzed sample was composed of 186 HIV-positive persons, and sample proportion with respect to population was 0.465 (186 out of 400).

Procedure
---------

This research was carried out taking into account the American Psychological Association's ethical principles[@b22-prbm-11-459] and was approved by the Experimental Deanery of Humanities and Arts of the West-Central University "Lisandro Alvarado", as well as by the authorities of PRONASIDA. The participants were asked to read and sign informed consent. They completed the assessment during their scheduled clinical appointments with health personnel. For participants with low level of literacy, the scale was administered as a structured, face-to-face individual interview. We informed participants that the collected data would be used for research purposes, with the aim of contributing to the design of behavioral intervention programs to improve their psychological condition, as well as to promote the practice of treatment adherence and health care behaviors that are needed to ensure an optimal clinical control of the disease. Participants did not receive any economic compensation for their participation in the study.

Measurement instruments
-----------------------

The SRSS-12 is composed of 12 items with a 10-point Likert-type response scale ranging from 1 = "no threatening at all" to 10 = "extremely threatening". The questions were based on different functional criteria representing situations that people face from the moment they have been diagnosed with a chronic disease and require a long-term treatment. Prior to the administration of the SRSS-12, a linguistic revision was made by psychologists assigned by the Department of Psychology of the University West-Central "Lisandro Alvarado" (located in the same city), who made minor adjustments in the wording of the items. The final version of the scale is shown in [Figure S1](#SD1-prbm-11-459){ref-type="supplementary-material"} and an English translation is shown in [Figure S2](#SD2-prbm-11-459){ref-type="supplementary-material"}. In their original version, the internal consistency of the 12 items was very high (raw Cronbach's alpha = 0.90), and the SRSS-12 included three factors that explained the 70.5% of total variance: DM, TA, and TF/I.[@b19-prbm-11-459]

The treatment-adherence behavior was measured with one close-ended question related to the frequency of days (per week) in which the participants consumed their anti-retroviral medication during last month. This question was used in the validation study of the Psychological Variables and Treatment-Adherence Behaviors Questionnaire performed in Venezuela.[@b23-prbm-11-459] The answer options were as follows: 1 = no day of the week; 2 = few days of the week (1--2 days); 3 = approximately half of the days of the week (3--4 days); 4 = most days of the week (5--6 days); 5 = every day of the week.

Statistical analysis
--------------------

The first step included testing the expected three-factor (3F-E) model through CFA. The Pearson correlation matrix (*r*) was used, being more adequate than that of polychoric correlations when the sample size is \<300 participants.[@b24-prbm-11-459] The multivariate distribution of the 12 items did not fit to a normal distribution (Mardia's multivariate asymmetry test: χ^2^=200.889, *P*\<0.001; Mardia's multivariate kurtosis test: χ^2^=365.109, *P*\<0.001, standardized value of Mardia's multivariate kurtosis =15.145), so the Scale-Free Least Squares was the method used to estimate the parameters, which does not assume multivariate normality and allows ordinal variables. The standard errors of the parameters were calculated by the Bias-Corrected Percentile method, extracting 2,000 bootstrap samples.

Six fit indices were considered: related chi-squared statistic (χ^2^/*df*), Standardized Root Mean Square Residual (SMSR), Jöreskog--Sörbom Goodness-of-Fit Index (GFI), Adjusted Goodness-of-Fit Index (AGFI), Bentler--Bonett Normed Fit Index (NFI), and Bollen's Relative Fit Index (RFI). The stipulated criteria for goodness of fit were χ^2^/*df*≤2, SMSR \<0.08, GFI, NFI, and RFI ≥0.95, AGFI ≥0.90, and the criteria for an acceptable fit were χ^2^/*df*≤3, SMSR \<0.10, GFI, NFI, and RFI ≥0.90, AGFI ≥0.85.[@b25-prbm-11-459] The parsimony of the model was estimated through the James--Mulaik--Brett Parsimony Ratio (PR). Values of PR ≥0.75 were interpreted as high parsimony, ≥0.50 as median, ≥0.25 as low, and \<0.25 as very low.[@b25-prbm-11-459]

Parsimonious index for NFI (PNFI) was calculated in relation to the independent model and for GFI (PGFI) in relation to the null model. PNFI values ≥0.80 and PGFI ≥0.60 were interpreted as good, whereas PNFI values ≥0.60 and PGFI ≥0.50 were considered as acceptable. It was considered that the goodness of fit between two models is equivalent when the quotient between the difference of the chi-squared statistic and the difference of the *df* of the models is less than or equal to 2 (Δχ^2^/Δ*df* ≤2), and the differences in the GFI, NFI, and RFI indices are ≤0.01.[@b25-prbm-11-459]

We used an EFA to identify a model with better properties of discriminant validity and fit to data. The number of factors was determined through four methods: 1) Horn's parallel analysis (extracting 500 samples generated by permutation of the data and using the 95th percentile as the cut-point, 2) the Raiche--Roipel--Blais optimal coordinate (OC) method (with the same specifications of Horn's parallel analysis), 3) Velicer's minimum average partial, and 4) the Kaiser's criterion (eigenvalues \>1). We were seeking the convergence of these four criteria.[@b26-prbm-11-459] The factors were extracted through minimum residual method that allows ordinal variables and does not require multivariate normality. The factorial matrix was rotated using the promax method.[@b24-prbm-11-459] We considered loads \>0.40 to retain the variables.[@b24-prbm-11-459]

Internal consistency was estimated using Cronbach's coefficient alpha for raw variables (α); values of α≥0.80 were interpreted as high internal consistency, ≥0.70 as adequate, ≥0.60 as questionable, and \<0.60 as low.[@b27-prbm-11-459] In order to establish whether a factor had convergent validity, the average variance extracted (AVE), calculated as the mean of the squared factor loads, was required to be greater than or equal to 0.50 (AVE ≥0.50). In order to establish whether two factors had discriminant validity, the AVE of each factor was required to be less than the square of the correlation between the two factors (shared variance), and less than two-thirds (AVE~F1~ and AVE~F2~ 2 \< r^2^ \<0.667).[@b28-prbm-11-459] To describe the distributions of factor scores, normality was tested by the Kolmogorov--Smirnov--Lilliefors test, and Fisher's kurtosis, skewness coefficients for samples, arithmetic mean, unbiased SD, and quartiles were calculated. The central tendency of the three factors was also compared through the Wilcoxon's signed rank test.

Results
=======

Participants' characteristics
-----------------------------

The majority of patients were male (80.1%), single (76.3%), and with a bachelor degree (59.1%). One-third had a CD4 cell count \>301, while 41.4% had undetectable viral load and 54.8% reported to be following pharmacological therapy every day of the month. The average number of months since the HIV-positive diagnosis at the time of the survey was 62.9 (SD=63.0; [Table 1](#t1-prbm-11-459){ref-type="table"}).

Factor structure, convergent and discriminant validity, and internal consistency
--------------------------------------------------------------------------------

The CFA of the 3F-E model yielded a permissible solution ([Figure 1](#f1-prbm-11-459){ref-type="fig"}). All three factors had acceptable internal consistency: raw Cronbach's alpha =0.79 for TF/I, 0.78 for TA, and 0.78 for DM. The factors of DM and TA had convergent validity (AVE~DM~ =0.587 and AVE~TA~ =0.554 \>0.50), but the TF/I factor did not (AVE~TF~=0.396 \<0.50). The DM factor showed discriminant validity with respect to the TF/I factor (AVE~DM~ =0.587 and AVE~TF~ =0.396\>*r*^2^ \[186\]=0.111 \<0.667) and TA (AVE~DM~ =0.587 and AVE~TA~=0.554\>*r*^2^ \[186\]=0.169 \<0.667). However, the factors of TA and TF/I lacked discriminant validity (AVE~TF~ =0.396 and AVE~TA~=0.554\<*r*^2^ \[186\] = 0.834 \>0.667). The goodness of fit of the model was good taking into account two indices (GFI =0.95 and AGFI =0.93) and acceptable through four indices (χ^2^/*df*=2.30, NFI =0.93, RFI =0.91, and standardized root mean square residual (SRMR) =0.09). The model showed a high parsimony (PR =0.77), with acceptable parsimonious indices (PGFI =0.62 and PNFI =0.71). The internal consistency of SRSS-12 was high (α=0.85).

Because of the problem of lack of discriminant validity, new models were proposed based on the EFA. The number of factors was two through Horn's parallel analysis and OC method. Based on the pattern and structure matrices, the configuration of two factors was as follows: TF/I and TA (items from 1 to 9; α=0.86) and DM (items from 10 to 12; α=0.78). Using the Velicer's and Kaiser's criteria, the number of factors was three. Based on the pattern and structure matrices, the configuration of three factors was as follows: TF/I and TA (items 1, 2, 5, 6, and 7; α=0.82); Follow-up of Instructions and Impulsivity (items 3, 4, 8, 9, and 10; α=0.78); and DM (items 11 and 12; α=0.91).

The two-factor model derived from EFA (2F-EFA) was tested; the solution was admissible ([Figure 2](#f2-prbm-11-459){ref-type="fig"}). The DM factor showed convergent validity (AVE =0.588), but the TF/I and TA factors did not (AVE =0.427). The percentage of shared variance between the two factors was 15.1%, so there was discriminant validity. The goodness of fit of the model was good taking into account two indices (GFI =0.95 and AGFI =0.93) and acceptable through four indices (χ^2^/*df*=2.28, NFI =0.92, RFI =0.91, and SRMR =0.09). The model showed a high parsimony (PR =0.80) with acceptable parsimonious indices (PGFI =0.65 and PNFI =0.74). The goodness of fit of this model was equivalent to that of the expected three-factor model (Δχ^2^/Δgl=3.522/2=1.761\<2 and; ΔGFI, ΔAGFI, ΔNFI, and ΔRFI\<0.01).

The three-factor model derived from EFA (3F-EFA) presented a problem related to having an insufficient number of indicators in the DM factor. Taking into account that item 10 of the Follow-up of Instructions and Impulsivity factor had its second highest load and was \>0.40 in the DM factor, this item was taken as an indicator of both factors. Thus, the minimum of three indicators was reached, and the factor coincided in its configuration with the expected factor (items 10, 11, and 12). When testing this three-factor model (3F-EFA), the solution was admissible ([Figure 3](#f3-prbm-11-459){ref-type="fig"}).

The three factors had convergent validity (TFA \[AVE=0.692\], Follow-up of Instructions and Impulsivity \[AVE=0.608\], and DM \[AVE =0.720\]). The shared variance ranged from 0.57 to 0.56, so all the three factors showed discriminant validity. The goodness of fit was good through five indices (χ^2^/*df*=1.47, SRMR =0.07, GFI =0.97, AGFI =0.95, and NFI =0.95) and acceptable through one index (RFI =0.94). The model showed a high parsimony (PR =0.72) with acceptable parsimonious indices (PGFI =0.62 and PNFI =0.75). When comparing the 3F-EFA model with the two previous models, the former model showed higher goodness of fit (Δχ^2^/Δgl \>2 and ΔGFI, ΔAGFI, ΔNFI, and ΔRFI \>0.01).

Distributions of factor scores
------------------------------

Based on the new factor model, scores on the TFA factor were obtained by adding items 1, 2, 5, 6 and 7. Scores on the Follow-up of Instructions/Impulsivity (FII) factor were obtained by adding items 3, 4, 8, 9 and 10. Finally, scores on the DM factor were obtained by adding items 10, 11, and 12. Then the sums were divided by the number of added items; in this way the score range was from 1 to 10. The distribution of TFA scores showed positive asymmetry (Sk =0.47, 95% CI: 0.12, 0.82) and platykurtosis (K=−0.78, 95% CI: −1.48, −0.09); the distribution of FII scores also showed positive asymmetry (Sk =0.64, 95% CI: 0.30, 0.99), but was mesokurtic (K=−0.585, 95% CI: −1.21, 0.11). The distribution of DM scores was symmetric (Sk=0.30, 95% CI: −0.05, 0.64), but showed platykurtosis (K=−1.10, 95% CI: −1.80, −0.41). No distribution followed a normal distribution based on the Kolmogorov--Smirnov--Lilliefors test.

The TFA average (arithmetic mean \[M\]=3.80, 95% CI : 3.48, 4.12) was not statistically different (Wilcoxon signed rank test: Z=−0.89, *P*=0.375) to FII average (M=3.97, 95% CI: 3.68, 4.27). Nevertheless, these two averages were significantly lower (Z=−6.20, *P*\<0.001 and Z=−7.14, *P*\<0.001, respectively) than DM average (M=4.96, 95% CI: 5.66, 4.12).

By dividing this continuous range into ten intervals of constant amplitude in correspondence with the ten ordinal values of the response to the items, the response labels to the items can be used to interpret the scores and means in the factors: \[1, 1.9\] → 1 = "not at all threatening", \[1.9, 2.8\] → 2 = "almost nothing threatening", \[2.8, 3.7\] → 3 = "very little threatening", \[3.7, 4.6\] → 4 = "little threatening", \[4.6, 5.5\] → 5 = "more or less threatening", \[5.6, 6.4\] → 6 = "something threatening", \[6.4, 7.3\] → 7 = "quite threatening", \[7.5, 8.2\] → 8 = "decidedly threatening", \[8.2, 9.1\] → 9 = "very threatening", and \[9.1, 10\] →10 = "extremely threatening". Consequently, the arithmetic means of TFA and FII in the interval \[3.7, 4.6\]) corresponded to "little threatening" (4), and the arithmetic mean of MD in the interval \[4.6, 5.5\]) corresponded to "more or less threatening" (5). The median for TFA (Mdn =3.6, first quartile \[Q~1~\]=1.8 and third quartile \[Q~3~\]=5.4) and FII (Mdn =3.6, Q~1~=2 and Q~3~=5.6) corresponded with an interval lower than the one of their arithmetic means (\[2.8, 3.7\] → 3= very little threatening). The Mdn for DM corresponded with the same interval than the one of its arithmetic mean (Mdn =4.83, Q~1~=3.33 and Q~3~=7.33).

Discussion
==========

When testing the expected three-factor model, it was revealed that there was a problem of discriminant validity between the TA factor and the Tolerance to Frustration factor, since the correlation between them was \>0.90. This finding led to a subsequent analysis with the aim of finding a new factor structure in which the factors had not only convergent and discriminant validity but also a high internal consistency. On the one hand, the EFA offered evidence of a two-factor model that matches the results reported in Peruvian women with breast cancer.[@b20-prbm-11-459] In the present study and Peruvian study, the TA factor and the Tolerance to Frustration factor merged into one single factor.

This finding might be explained by the fact that the stress associated with living with a chronic disease and the prescription of long-term therapies demands extensive personal resources,[@b29-prbm-11-459] and TFA might become essential in this context, since the therapeutic program not only includes medication adherence but also a change of the life style (diet, exercise and hours of sleeping).[@b30-prbm-11-459],[@b31-prbm-11-459] It should be noted that the two-factor model was supported by Horn's Parallel Analysis and by Raiche--Roipel--Blais OC method, which are considered the most solid strategies for determining the number of factors.[@b26-prbm-11-459] On the other hand, the EFA revealed a three-factor structure; in this model, the two factors with insufficient discriminant validity had a different configuration; one of these factors was composed of items related to TFA, while the other one was composed of items related to Follow-up of Instructions and Impulsivity.

It is important to remark that one of the items included in the DM factor (item 10) had its highest load (close to 0.50) on the Follow-up of Instructions and Impulsivity factor, while its second highest load (and \>0.40) was found on its expected location, within the DM factor. This caused that, in the CFA, this item became an indicator of both factors (cross loading), so that the DM factor could be defined by, at least, three indicators, as it is recommended for the factor analysis.[@b24-prbm-11-459],[@b25-prbm-11-459] This specification allowed obtaining a model that showed appropriate goodness of fit (from good to acceptable with a domain of good fit values), had convergent and discriminating validity on its factors, as well as good internal consistency. It will be necessary to analyze in future studies the conceptual structure of this model, including persons living with HIV and persons suffering from other chronic diseases (eg, diabetes, cardiovascular diseases and cancer), in order to identify the magnitude and the way in which this model applies to the assessment of the different dimensions that have been studied in this research.

When comparing the two-factor model and the three-factor model derived from EFA, the latter one had the best values of internal consistency, AVE, and goodness of fit, in addition to showing high parsimony. Furthermore, the three-factor model showed discriminant validity, and its contents were clearly interpretable. The three factors can be justified through Kaiser's criterion, although Kaiser's criterion tends to be discouraged to determine the number of factors because it does not take into account sampling error.[@b26-prbm-11-459] Velicer's analysis also holds that there were three substantive factors that were explaining shared variance and not the spurious variance.[@b26-prbm-11-459] Therefore, all these findings together ensure that the three-factor model is the best solution.

Because the scale was developed in light of a theoretical model,[@b8-prbm-11-459],[@b9-prbm-11-459],[@b15-prbm-11-459] it is necessary to clarify if these variables of personality should be considered as a part of a set of psychological variables, including the motives to behave and the behavioral competencies. Therefore, the potential implications of the findings reported here and for subsequent studies, lie in the probability of obtaining accurate information about how it is that the variables of the most distal (personality) and the most recent (motives and behavioral competencies) history interact facilitating or limiting the practice of the medication adherence and health care behaviors. In that sense, the type of intervention program that is designed to improve the psychological condition and the practice of both types of behaviors will depend on the way in which the personality variable modulates the operation of motives and behavioral competencies. The research background based on the theoretical model constitutes a reference that is now taken into account in the context of the disease rehabilitation, as are the cases of HIV/AIDS, diabetes, cancer, and hypertension.[@b32-prbm-11-459]--[@b36-prbm-11-459]

This study showed that the situations of Ambiguity due to secondary effects, efficacy of medication, and control of the irritability generated by treatment adherence and Follow-up of Instructions were little threatening, but situations that involve Decision Making about other options of treatment (home remedies and naturopathy) are more or less threatening. Therefore, it seems that patients feel calm and confident in their medical treatment, and feel stressed by any questioning of their current treatment, as shown by studies on satisfaction with antiretroviral therapy.[@b37-prbm-11-459]

At least three limitations should be considered in our study. First, since we worked with a nonprobabilistic sample the results do not constitute estimates of population parameters, but should be handled as hypotheses in future studies. Second, the size of the sample did not reach the minimum of 200 recommended for performing CFA, partly owing to the characteristics of the institution in which the study was performed; however, there were more than 15 participants per item, more than 5 participants per estimated parameter, and the average effect size of the factors on their indicators was high. Third, because the sample was restricted to HIV-positive cases without meeting AIDS criteria, any generalization of the results to cases with AIDS requires further demonstration. Strengths of the study are the use of appropriate analysis techniques for ordinal variables that do not fulfill multivariate normality, as well as the use of rigorous methods to determine the number of factors in the EFA.

Conclusion
==========

The internal consistency of the scale was high, not requiring the elimination of any item. The expected three-factor model showed a severe problem of discriminant validity in two of its factors. The convergence of criteria for determining the number of factors indicated the existence of two factors (parallel analysis and OC method) or three factors (Velicer's and Kaiser's criteria). In the two-factor model, one of the factors lacked convergent validity, and the goodness-of-fit indices with values not beyond the acceptable range prevailed; in this model, the two factors without discriminant validity from the expected three-factor model were merged into one. In the new three-factor model specified in this research and derived from EFA, the three factors had convergent and discriminant validity, values of internal consistency varied from acceptable to high, the goodness of fit was good, and the goodness of fit of this model was greater than the one of other two models; thus, this last model would be the best option. In this model, the two factors without discriminant validity from the expected three-factor model showed a different configuration. The distributions of factor scores did not follow a normal curve, so that can be scaled using percentile scores.

In future studies, it is suggested to test the new three-factor model (TFA \[items 1, 2, 5, 6, and 7\], Follow-up of Instructions and Impulsivity \[items 3, 4, 8, 9, and 10\], and DM \[items 10, 11, and 12\]), using multigroup analysis across gender (women vs men) and different clinical populations (HIV-positive patients vs AIDS patients), reaching a minimum size of 200 participants per group. As a new step in the adaptation of the SRSS-12, researchers could estimate the norms and cutoff points to interpret the raw scores on the scale and its factors. For this purpose, probability sampling should be used; likewise, two groups could be distinguished: one with adherence to treatment and another without adherence to treatment.

Another suggestion would be to perform a systematic study of the personality variables in relation to other psychological processes or variables included in the personality theory on interactive styles (eg, motives, behavioral competencies, and mood states),[@b38-prbm-11-459] in order to obtain specific indicators of their joint influence on the function of the immune system and other biological markers among people living with HIV. Finally, the main goal shall be to achieve valid and reliable information that allows us to design, implement, and evaluate theoretically justified behavioral intervention programs to promote or improve the efficient and consistent practice of therapy adherence and health care behaviors in persons living with HIV in Venezuela.[@b39-prbm-11-459],[@b40-prbm-11-459]

Supplementary materials
=======================

A continuación se le presentan una serie de preguntas que tienen que ver situaciones que usted eventualmente enfrenta día a día. En una escala del 1 al 10, indíquenos como evalúa usted qué tan amenazantes le resultan esas situaciones, donde 1 es igual a nada amenazante y 10 es igual a demasiado amenazante.

Below, a series of questions about situations that you eventually face day by day are presented. On a scale from 1 to 10, tell us how you evaluate how threatening these situations are, where 1 means not at all threatening, 5 more or less threatening, and 10 extremely threatening.

###### 

The 12-item Stress-Related Situations Scale (Venezuelan adaption in Spanish).

**Notes:** Adapted from Piña JA, Valencia MA, Mungaray K, Corrales AE. Validación de una escala breve que mide situaciones vinculadas con estrés en personas VIH positivas \[Validation of a short scale that measures stress related events in HIV positive patients\]. *Ter Psicol*. 2006;24(1):15--21. Spanish. Copyright 2006 by Sociedad Chilena de Psicología Clínica.[@b41-prbm-11-459] This Venezuelan version of the SRSS-12 was adapted by psychologists assigned by the Department of Psychology of the University West-Central "Lisandro Alvarado", who made minor adjustments in the wording of the items and instructions (highlighted in blue).

###### 

The 12-item Stress-Related Situations Scale (English translation of the Venezuelan adaption).

**Notes:** Translated and adapted from Piña JA, Valencia MA, Mungaray K, Corrales AE. Validación de una escala breve que mide situaciones vinculadas con estrés en personas VIH positivas \[Validation of a short scale that measures stress related events in HIV positive patients\]. *Ter Psicol*. 2006;24(1):15--21. Spanish. Copyright 2006 by Sociedad Chilena de Psicología Clínica.^1^ This English version of the SRSS-12 was adapted by psychologists assigned by the Department of Psychology of the University West-Central "Lisandro Alvarado". Minor adjustments in the wording of the items and instructions have been done. The translation was conducted by the authors of this article.
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![Expected three-factor (3F-E) model.\
**Note:** e1--e12 measurement residuals.](prbm-11-459Fig1){#f1-prbm-11-459}

![Two-factor model derived from EFA.\
**Note:** e1--e12 measurement residuals.\
**Abbreviation:** EFA, exploratory factor analysis.](prbm-11-459Fig2){#f2-prbm-11-459}

![Three-factor model derived from EFA.\
**Note:** e1--e12 measurement residuals.\
**Abbreviation:** EFA, exploratory factor analysis.](prbm-11-459Fig3){#f3-prbm-11-459}

###### 

Sociodemographic, clinical, psychological, and behavioral characteristics of participants

  Variables                                    M       SD      Min/Max   n     \%
  -------------------------------------------- ------- ------- --------- ----- ------
  Age                                          34.97   9.98    18--66          
  Gender                                                                       
   Male                                                                  149   80.1
   Female                                                                37    19.9
  Marital status                                                               
   Single                                                                142   76.3
   Divorced                                                              20    10.8
   Married                                                               19    10.2
   Widowed                                                               5     2.7
  Schooling                                                                    
   Illiterate                                                            4     2.2
   Primary                                                               11    5.9
   Secondary                                                             92    32.8
   Bachelor                                                              61    50.0
   Postgraduate                                                          17    9.1
  Time since HIV+ diagnosis (months)           62.90   63.09   6--492          
  CD4 cell counts (cells/mL)                                                   
   \<200                                                                 42    22.6
   201--300                                                              81    43.5
   \>301                                                                 63    33.9
  Viral load (copies/mL)                                                       
   Undetectable                                                          77    41.4
   \<1,00,000                                                            76    40.9
   \>1,00,000                                                            33    17.7
  Personality factors                                                          
   Tolerance to Frustration and Ambiguity      3.80    2.21    1--10           
   Follow-up of Instructions and Impulsivity   3.97    2.06    1--10           
   Decision Making                             5.31    2.41    1--10           
  Adherence behaviors (weeks)                                                  
   Few days (1--2 days)                                                  25    13.4
   Most of the days (5--6 days)                                          59    31.7
   All days (7 days)                                                     102   54.8

**Note:** Sample size (N) =186.

**Abbreviations:** M, mean; Min, minimum value; Max, maximum value; n, simple absolute frequency.
